Evidence map›Paper›PMID 30886220›Full record

ArticleScientific reports2019

Association between acute kidney injury and serum procalcitonin levels and their diagnostic usefulness in critically ill patients.

Kayeong Chun, Wookyung Chung, Ae Jin Kim, Hyunsook Kim, Han Ro, Jae Hyun Chang, Hyun Hee Lee, Ji Yong Jung

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kayeong ChunDivision of Nephrology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
Wookyung ChungDivision of Nephrology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
Ae Jin KimDivision of Nephrology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
Hyunsook KimGachon Medical Research Institute, Incheon, Korea.
Han RoDivision of Nephrology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
Jae Hyun ChangDivision of Nephrology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
Hyun Hee LeeDivision of Nephrology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
Ji Yong JungDivision of Nephrology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea. jyjung@gachon.ac.kr.ORCID 0000-0003-1271-8012
Gachon University · KRGachon University Gil Medical Center · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Procalcitonin (PCT) is a useful marker for the diagnosis of systemic inflammatory response syndrome. In addition, PCT is affected by renal function. However, few studies have investigated the relationship between PCT and the development of acute kidney injury (AKI). Hence, we investigated whether serum PCT levels at the time of admission were associated with the development of AKI and clinical outcomes. A total of 790 patients in whom PCT was measured on admission to the intensive care unit (ICU) were analyzed retrospectively. We attempted to investigate whether serum PCT levels measured at the time of admission could be used as a risk factor for the development of AKI in septic and nonseptic patients or as a risk factor for all-cause mortality, and diagnostic usefulness of PCT was further assessed. Serum PCT levels were significantly higher in patients with AKI than in those without AKI (P < 0.001). After multivariable adjustment for clinical factors, laboratory findings, and comorbidities, PCT as a continuous variable showed a significant association with AKI (OR 1.006, 95% CI [1.000-1.011]; P = 0.035). However, PCT was not effective in predicting mortality. The cut-off value of PCT for the prediction of AKI incidence was calculated to be 0.315 ng/ml, with sensitivity and specificity of 60.9% and 56.9%, respectively. The odds ratios (ORs) from an equation adjusted for optimum thresholds of PCT levels for developing AKI with and without sepsis were 2.422 (1.222-4.802, P = 0.011) and 1.798 (1.101-2.937, P = 0.019), respectively. However, there were no absolute differences between the pre- and posttest probabilities after including the PCT value for AKI development. This study suggests that the PCT value was higher in AKI patients than in non-AKI patients, but PCT measurement at the time of admission did not improve the prediction model for AKI.

Indexed as

Acute Kidney InjuryAdultAgedBiomarkersCritical IllnessFemaleHumansMaleMiddle AgedProcalcitoninBiomarkersProcalcitonin

Identifiers

PMID30886220
PMCPMC6423019
OpenAlexW2921824498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.